These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 5631922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FDA regulatory requirements for investigational new drugs and new drug applications: an update.
    Hoiberg CP, Rapaka RS.
    NIDA Res Monogr; 1991; 112():313-25. PubMed ID: 1754003
    [No Abstract] [Full Text] [Related]

  • 4. Responsible extra-label use of drugs.
    Cobb DV.
    J Am Vet Med Assoc; 1996 Nov 01; 209(9):1545. PubMed ID: 8899012
    [No Abstract] [Full Text] [Related]

  • 5. Comments about vitamins, nutraceuticals, and dietary enzymes.
    Henderson TR.
    J Am Vet Med Assoc; 1995 Jul 01; 207(1):31. PubMed ID: 7601686
    [No Abstract] [Full Text] [Related]

  • 6. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2005 Nov 23; 70(225):70720-30. PubMed ID: 16304736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Separate manufacturing standards needed for veterinary drugs: AVMA.
    J Am Vet Med Assoc; 1996 Feb 15; 208(4):461. PubMed ID: 8603886
    [No Abstract] [Full Text] [Related]

  • 10. The parenteral drug industry: recent findings.
    Fry EM.
    J Parenter Sci Technol; 1982 Feb 15; 36(2):55-8. PubMed ID: 7077464
    [No Abstract] [Full Text] [Related]

  • 11. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep 29; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. How do drugs get their brand names?
    Novack GD.
    Ocul Surf; 2012 Apr 29; 10(2):117-20. PubMed ID: 22482472
    [No Abstract] [Full Text] [Related]

  • 16. Fake biotech drugs raise concerns.
    Fox JL.
    Nat Biotechnol; 2001 Jul 29; 19(7):603. PubMed ID: 11433258
    [No Abstract] [Full Text] [Related]

  • 17. Reaction of FDA to a fundamental change in the nature of regulations.
    Kennedy D.
    J Parenter Drug Assoc; 1979 Jul 29; 33(1):17-20. PubMed ID: 253023
    [No Abstract] [Full Text] [Related]

  • 18. Dietary supplements: background for dialogue between the industry and the medical profession.
    Friede AI.
    Food Drug Law J; 1998 Jul 29; 53(3):413-20. PubMed ID: 10346719
    [No Abstract] [Full Text] [Related]

  • 19. Drug regulation and policy formulation.
    Nightingale SL.
    Milbank Mem Fund Q Health Soc; 1981 Jul 29; 59(3):412-44. PubMed ID: 7024847
    [Abstract] [Full Text] [Related]

  • 20. Industry perspectives on ICH guidelines.
    Rockhold FW.
    Stat Med; 2002 Oct 15; 21(19):2949-57. PubMed ID: 12325111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.